Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Lugalbanda
    Junior Member
    • Oct 2016
    • 3

    #1

    DESeq factor design, and optimal number of samples

    For the 1st question, I want to know if I should run a single factor or double factor. These samples are match normal/tumor from different patients so something like this

    p1N p1T p2N p2T p3N p3T

    do i have to run a double factor run like this:

    ------------condition---------patientNumber
    ------------<factor>--------- <factor>
    p1N--------normal------------ 1
    p1T----------tumor ------------1
    p2N---------normal-------------2
    p2T----------tumor--------------2
    p3N--------normal-------------3
    p3T---------tumor--------------3


    or a single factor like this:

    -------------Condition
    -------------<factor>
    p1N--------normal
    p1T---------tumor
    p2N--------normal
    p2T---------tumor
    p3N--------normal
    p3T---------tumor


    I suppose the question boils down to whether or not DESeq cares if samples come from different patients.

    For the 2nd question, I have a thousand match normal/tumor from the same type of tissue but from different patients, should I run DESeq on all one thousand of them or is it fine to do a smaller amount like one hundred?
    Last edited by Lugalbanda; 10-05-2016, 01:53 PM. Reason: formatting
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    If you have tumour/normal pairs, then you should include the pairing information

    Code:
    design = ~patientNumber + condition
    DESeq2 (there's no reason to use DESeq) can get rather slow with 1000 samples. You'd be better with limma in that case.

    Comment

    • SylvainL
      Senior Member
      • Feb 2012
      • 180

      #3
      Hi dpryan,

      how slow for 1000 samples?

      Comment

      • dpryan
        Devon Ryan
        • Jul 2011
        • 3478

        #4
        @SylvainL: Good question and I don't know the answer to that. Perhaps Mike Love will pop by the thread and give a guesstimate.

        Comment

        • fanli
          Senior Member
          • Jul 2014
          • 197

          #5
          It seems from the cancer literature that most/all studies using a paired tumor-normal design only have one sample from each (e.g. p1T, p1N) and not in replicate (e.g. p1Ta, p1Tb, p1Tc, p1Na, p1Nb, p1Nc). Is that appropriate, or would it be better to do things in triplicate? Say by splitting a tumor sample into 3 sections?

          Comment

          • SylvainL
            Senior Member
            • Feb 2012
            • 180

            #6
            Your replicates are paired (p1T, p1N, p2T, p2N, etc...) so there is no need to split.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
              by SEQadmin2




              NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
              Today, 06:46 AM
            • SEQadmin2
              Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
              by SEQadmin2



              Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

              Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
              ...
              10-14-2026, 09:55 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 10-28-2026, 09:57 AM
            0 responses
            22 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-28-2026, 09:51 AM
            0 responses
            14 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-22-2026, 11:13 AM
            0 responses
            67 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-22-2026, 10:48 AM
            0 responses
            47 views
            0 reactions
            Last Post SEQadmin2  
            Working...